TRANSCAN-3 launches its fourth transnational call (JTC 2024)

With the support of 21 funding organisations from 16 different countries, TRANSCAN-3 has launched a call for research proposals on the topic of: “Combination therapies against cancer: new opportunities for translational research ”

The expected impact of the call is to improve the efficacy of personalized treatment of cancer patients through the development of new combinatorial treatment strategies, based on a better understanding of drug mechanistic functions and of their impact on the disease course. The specific objectives of this funding opportunity are to stimulate new partnerships between researchers and clinicians and support original, high-quality projects, with significant clinical impact.